Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL16612173

O=C1CCC(=O)N1I.O=S(=O)([O-])C(F)(F)F.[Ag+]

nearest known ligand 0.32

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

folP

The experimentally established mechanism targets of Trifluoromethanesulfonic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1293200-A Process for preparing saponin library by one-step or two-step random reaction SHANGHAI INST ORGANIC CHEM (CN) 2001-05-02 CN claimed
CN-1293199-A Saponin library of rhammose-substituted beta-o-gluco-diosgenin and its preparing process and application SHANGHAI INST ORGANIC CHEM (CN) 2001-05-02 CN claimed
EP-2857411-B1 METHOD FOR PREPARING FULLY PROTECTION HEPARIN PENTASACCHARIDE AND INTERMEDIATE THEREOF ZHEJIANG HISUN PHARM CO LTD (CN) 2017-12-06 EP disclosed
US-20150284419-A1 METHOD FOR PREPARING FULLY PROTECTION HEPARIN PENTASACCHARIDE AND INTERMEDIATE THEREOF ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) 2015-10-08 US disclosed
EP-2857411-A1 METHOD FOR PREPARING FULLY PROTECTION HEPARIN PENTASACCHARIDE AND INTERMEDIATE THEREOF Zhejiang Hisun Pharmaceutical Co. Ltd. (CN) 2015-04-08 EP disclosed
CN-104169292-A Method for preparing fully protection heparin pentasaccharide and intermediate thereof ZHEJIANG HISUN PHARM CO LTD 2014-11-26 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150284419-A1 METHOD FOR PREPARING FULLY PROTECTION HEPARIN PENTASACCHARIDE AND INTERMEDIATE THEREOF HABP2, HPSE, PLG GPR3 4756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.